Healthcare major Apollo Hospitals Enterprise Thursday reported a 28.57 per cent rise in standalone net profit to Rs 76.68 crore for the fourth quarter ended March 31, on account of strong performance across verticals.
The company had posted a net profit of Rs 59.64 crore in the same period of 2017-18, Apollo Hospitals Enterprise said in a BSE filing.
Standalone revenue from operations stood at Rs 2,167.11 crore for the quarter under consideration. It was Rs 1,863.42 crore for the same period a year ago.
The company said its earnings before interest, tax, depreciation and amortisation (EBITDA) in FY19 crossed landmark of Rs 1,000 crore for the first time.
Apollo Hospitals has delivered a strong performance in the final quarter of the year, with continued growth of volumes, revenues and margins. There was a good performance, both in the hospitals and in the pharmacy division, the company said.
For the 2018-19 fiscal, the net profit of the company rose to Rs 302.76 crore as against Rs 233.20 crore in the preceding fiscal.
The company's revenue from operations in 2018-19 stood at Rs 8,336.66 crore. It was Rs 7,183.01 crore for 2017-18.
"I am pleased that we have consolidated our position as India's largest private healthcare provider in FY18-19, with our numbers signalling robust growth across multiple verticals," Apollo Hospitals Chairman Prathap C Reddy said.
Standalone revenues of the healthcare services division grew 14 per cent to Rs 4,450.6 crore in FY19 compared to Rs 3,914.1 crore in FY18, Apollo Hospitals said.
"We added 490 stores and closed 83 stores for a net addition of 407 stores in FY19. The total store network as of March 31, 2019 stands at 3,428 operational stores," it added.
Revenues grew by 19 per cent to Rs 3,886 crore in FY19 from Rs 3,268.9 crore in FY18.
The company's board has recommended a dividend of Rs 6 per share (120 per cent of face value of Rs 5 each) for the financial year ended March 31, 2019 on the paid up equity shares of the company, Apollo Hospitals said.
Shares of Apollo Hospitals Enterprise were trading at Rs 1,204.90 per scrip on the BSE, up 0.13 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
